How the Monkeypox Vaccine Scam Mirrors the COVID Vaccine Scam: Animal Trials show Monkeypox Vaccine does NOT Stop Transmission

Just like the COVID vaccines, turns out that in the animal experiments, Jynneos did not stop monkeys getting monkeypox, but did stop them from dying.   Since the current strain of monkeypox is mild, and virtually no one dies from monkeypox, this is another reason to avoid these dangerous vaccines like the plague—they won’t stop the infection! The US Government has created a fake shortage of vaccine. Well yes, of course, they always do that to fan the flames of demand. But this is a lot bigger than that. The USG already owns 16 million doses, stored frozen in Denmark, and had spent well over $1 Billion on Jynneos vaccines before Moneypox was identified in the west. Despite the Denmark factory's "fill and finish” facility being completed in 2021, and despite the USG allotting $44 million for “qualification” of that same facility in January 2019, the FDA only got around to finishing its inspection on July 27, 2022.   Because of the vaccine "shortage," the existing vaccine will get a liability waiver. How sweet is that? Jynneos is licensed, and is being used for its labelled indication (prevention of Moneypox) so the manufacturer is liable for injuries. The USG might also be liable, if it steered you wrong about the safety or efficacy of the vaccine…or if it hid a study it had conducted, for example. But since we have a shortage, the USG in its benevolence and wisdom is going to dilute it and give recipients instead a 20% dose, administered intradermally instead of subcutaneously. But in order to make this kosher (kosher for whom?) the DHHS and FDA are issuing the vaccine an emergency use authorization, and we all know what that means. You can’t sue anybody even if the vaccine kills you.

Is the Untested and Dangerous Monkeypox Vaccine About to get an EUA to Avoid Legal Liability for Deaths and Injuries?

We saw throughout the COVID Plandemic that the pharmaceutical industry took advantage of "Public Health Emergency" designations to get the FDA to issue EUAs (emergency use authorization) to get new, untested vaccines into the market as soon as possible without proper testing, and more importantly for the pharmaceutical companies, no legal liabilities. With the W.H.O. and the U.S. Government now declaring monkeypox to be a "Public Health Emergency," could the same thing happen with new vaccines and drugs for monkeypox? The problem in issuing the existing smallpox/monkeypox vaccine an EUA, is that it was already approved by the FDA, even though it has not been tested in the public much beyond the initial trials conducted by the drug company. According to Dr. Meryl Nass, that may not stop them from figuring out a way to get the FDA to issue them an EUA to avoid legal liability: "Although I don't have the full story yet, I am warning you that the moneypox vaccine Jynneos is a huge scam, in every way, including the supposed shortage.  I will disclose more about that soon. But since it is actually licensed, the moneypox vaccine (like other licensed drugs and vaccines) has liability attached to it.  You can currently sue government program planners, the doctor who recommended it, the manufacturer, etc. if anything goes wrong. To forestall that, some crook came up with the idea of splitting the doses, under the guise of a fake shortage, which provides an excuse to make the lower dose an EUA--in other words, turning it into a product for which you cannot sue anyone if something goes wrong.  Pretty clever, eh?   Licensed products are not supposed to receive EUAs unless they are used for something different than what they were licensed for.  Splitting the dose does not change the fact it is licensed for monkeypox and being used for moneypox. Here is another possible but diabolical reason to split (dilute) the dose:  it potentially allows the federal government access to the vials--so the vials won't go straight from the manufacturer to the wholesaler but instead go somewhere else to be diluted.  And what is in the diluent?"

WHO Declares Monkeypox “Global Emergency” After Vaccine Approved by EMA for Europe – Outbreaks are Only in Countries That Injected Their Citizens with Pfizer COVID Shots

The roll out of the Monkeypox "Plandemic" has been carefully planned and coordinated, much like the COVID Plandemic of 2020, including having simulations on how this "plandemic" will evolve, much like the 2019 Event 201 which simulated, with almost precision accuracy, how the COVID plandemic would evolve. This past weekend the World Health Organization officially declared the “monkeypox outbreak” a Public Health Emergency of International Concern (PHEIC). An important event had to occur before this announcement, however, and that happened on Friday last week, when the European Medicines Agency (EMA) approved Bavarian Nordic Smallpox/Monkeypox vaccine for distribution in Europe, so that Big Pharma can continue reaping windfall profits from vaccines that are supposed to stop "plandemics." This vaccine, while approved by the FDA in the US and now by the EMA in Europe, is largely untested in the public, and there were very serious issues with rates of heart disease in the clinical trials, which are actually higher than the rates of heart disease for the experimental COVID-19 mRNA vaccines. The World Health Organization has acknowledged that the vaccine is mostly untested, and that those being injected with the vaccine now are part of a “clinical study” for the purpose of data collecting so that researchers can learn more about the “effectiveness of the vaccine.” And perhaps the most interesting aspect of this planned and coordinated MonkeyPox "outbreak" was reported by The Exposé yesterday, where their investigation revealed that the only countries where these "outbreaks" of MonkeyPox are happening are only in countries where the Pfizer COVID-19 vaccine has been injected into the citizens of those countries in mass vaccination campaigns. Russia and China, therefore, are allegedly not seeing these MonkeyPox "outbreaks," and "coincidentally" they did not mass vaccinate their populations with American-made Pfizer COVID vaccines, but used their own, locally produced, COVID vaccines.

Pro-Vaccine Masses Who Survived COVID Injections Targeted for Monkeypox Vaccines as Depopulation Plans Advance

The vaccine industry is committing suicide. It was announced this week that the CDC has ordered 1.6 million doses of Bavarian Nordic's smallpox and monkeypox vaccines to be injected into people during the second half of 2022, starting with 56,000 doses immediately, another 240,000 doses in the coming weeks, then another 750,000 doses over the rest of the summer with another 500,000 doses in the fall. With the carnage that has just occurred for the past 18 months where 7,478,300 people were killed and 583,023,500 people were injured by experimental COVID shots in the U.S. and Europe, who in the world would fall for the lies of Big Pharma and their crony politicians again, and sign up to get these shots? Certainly not the anti-vaxxers, and certainly not those who were foolish enough to get the COVID shots, were injured by them, and then woke up to the fact that they were lied to and hence suffered tremendously. No, these shots are obviously targeting those who survived the COVID shots, believed the shots somehow conferred benefit on them since they are still alive and breathing, and trust the medical tyrants to cure their fear of the fake monkeypox pandemic which has not even really started yet. Most of them are probably suffering some kind of skin infection that was probably produced as a side effect from the COVID shots, such as shingles, and they will be led to believe they have some dreaded new form of monkeypox that needs another vaccine. This is vaccine marketing suicide, as they are killing off and crippling the vaccine cult members, and destroying their repeat business. Obviously reducing the world's population is a worthy goal in their minds, so much so they are sacrificing the future of the vaccine business model by destroying their future customers.